C. diff is considered an “urgent health threat” by the CDC and 1 in 4 patients with C. diff will get it again. Previously, patients with recurrent C. diff were limited by options that treated the infection but left them vulnerable to yet another recurrence, keeping them in a constant state of fear.
As the only microbiome treatment in oral capsules to prevent recurrent C. diff, VOWST empowers patients to stand triumphantly over the C. diff monster that has haunted their lives (and bathrooms) over and over again.
Patient Website
The C. diff monster comes to life on VOWST.com before being defeated by our VOWST-empowered patient. The site provides important information on recurrent C. diff and how VOWST is not a probiotic, but an FDA-approved microbiome treatment to keep C. diff from attacking again.
Patient Brochure
The provocative cover piques interest in the waiting room, providing C. diff
patients with information on VOWST prior to discussing it with their doctor.
Over 360,000 site visits
in first 8 months, largely
from paid media
38% website
engagement rate
Social click-thru rates
131% higher than industry
benchmarks of 0.75%
Display click-thru rates
nearly 2x industry
benchmarks
Paid Social
Recurrent C. diff patients are vocal and active in social spaces. Video was shown to be a prominent social driver, allowing us to tell our story with animated C. diff monster imagery coupled with straightforward headlines and CTAs to get patients to the website.
Display Ads
Display ads remind patients concerned about a recurrence
that VOWST works to prevent yet another C. diff attack.
A step-by-step video on taking VOWST
While VOWST is taken as oral capsules over 3 days, it does require carefully coordinated timing following a course of antibiotics and a laxative. This patient-friendly video breaks down the steps in an inviting way to set patients up for success.